Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.
Picked up on the news as well! http://shares.telegraph.co.uk/news/article.php?id=4695808&epic=SVCA
About to tick upwards again!
Just paid!
Few shares on offer and she's climbing!
The Company is pleased to report that results for the year ended 30 September 2013 will be significantly ahead of market expectations and the Board is encouraged by the continued performance of the Group.
Just paid!
Now up 27%!!! She has a tiny market cap and should move very easily!
6.30p just paid!
Of Blue:)
...
Getting a 5.10p sell now:)
Up 21%!
30 October 2013 Servoca Plc ("Servoca" or "the Company") Trading update Servoca, the specialist outsourcing and recruitment solutions provider, announces an update on trading following its year ended 30 September 2013. The Company is pleased to report that results for the year ended 30 September 2013 will be significantly ahead of market expectations and the Board is encouraged by the continued performance of the Group. The September period, which is important for the Group's Education recruitment businesses, was positive and a marked improvement on the prior year. Trading in the second half and the platform established from our Education activities give the Board confidence on further growth in 2014. Servoca expects to announce its preliminary results to 30 September 2013 in January 2014. Servoca Plc Andrew Church Glenn Swaby 020 7747 3030 FinnCap Geoff Nash/Ben Thompson Simon Starr (broking) 020 7220 0500 Newgate Threadneedle Graham Herring Robyn McConnachie 020 7653 9850 This information is provided by RNS The company news service from the London Stock Exchange END TSTKBLBXXBFLFBF
About to have an upwards tick:)
Showing as sells...
Platform Acquisition Holdings Limited Symbol: PAH 29 October 2013 Platform Acquisition Holdings Limited ("Platform" or the "Company") today publishes its interim management statement for the period from 1 July 2013 to 29 October 2013. Platform was admitted to the London Stock Exchange on 22 May 2013 through an initial public offering ('IPO'), raising gross proceeds of $905 million, consisting of $885 million through the placing of ordinary shares (with matching warrants) at a placing price of $10 per ordinary share and a further $20 million through the subscription of founder preferred shares. As set out in Platform's Prospectus dated 17 May 2013, the Company was formed with the strategy of acquiring a target company or business expected to have an enterprise value of between $750 million and $2.5 billion. As at Platform's last close of trading on the London Stock Exchange on 10 October 2013, Platform had 88,529,500 ordinary shares in issue, 2,000,000 founder preferred shares in issue and 90,529,500 warrants (each warrant being exercisable for 1/3 of an ordinary share). As of 30 September 2013, Platform had cash of approximately $364.5 million and also held $516.0 million in United States Government Treasury Bills, $336.0 million of which are classified as cash equivalents due to having a maturity of less than three months from the date of purchase. The Net Loss for the period 1 July 2013 to 30 September 2013 was $4.7 million including $4.5 million of expenses related to the pending MacDermid transaction described below. As previously announced, on 10 October 2013, Platform entered into a definitive agreement to acquire MacDermid Incorporated ("MacDermid"), a global provider of specialty chemicals for approximately $1.8 billion plus deferred consideration. The transaction is expected to complete by the end of October 2013. After the assumption of $755 million of existing MacDermid first lien indebtedness, the remaining cash consideration is expected to be funded with Platform's cash on hand and proceeds from a warrant exchange offer being carried out by Platform. Since 10 October 2013, Platform's shares and warrants have been suspended from trading on the London Stock Exchange and it is not expected that trading will resume as Platform expects to complete a listing of its shares on the New York Stock Exchange as soon as practicable. Following the completion of Platform's acquisition of MacDermid, Platform will be renamed Platform Specialty Products Corporation ("PSP") and MacDermid will continue to operate as a standalone business by its existing management team, under the PSP umbrella. PSP intends to change the composition of its Board of Directors in anticipation of its move from the London Stock Exchange to the New York Stock Exchange. Martin E. Franklin, Founder and Executive Chairman of Jarden Corporation, will serve as PSP's Chairman, to provide ongoing strategic guidance ov
MIDAS SHARE TIPS EXTRA: New British solar energy fund has chance to shine as Government expects solar to play a growing role in electricity production To many, the idea of solar power in Britain sounds ludicrous, especially as winter nears. But solar energy relies on light rather than heat and the UK has more than enough of that, particularly in the South. The cost of plants has also fallen and the Government expects solar energy to play a growing role in the electricity sector. Solar panels turn light into energy Bright future: Solar panels turn light into energy Foresight Solar Fund intends to tap into this trend and is also scheduled to float this month. Shares will be offered at 100p and a dividend of 6p is planned, rising in line with inflation. The £200 million flotation is similar to recent wind fund offerings, but solar energy is more predictable and the plants tend to attract less opposition. For investors seeking long-term income, the shares are a good bet. Foresight is an investment firm that has been involved in green energy and other infrastructure projects for almost 30 years. http://www.thisismoney.co.uk/money/investing/article-2445771/MIDAS-SHARE-TIPS-Foresight-Solar-Fund-scheduled-float-month.html
FTSV is receiving a very warm welcome:) http://www.thisismoney.co.uk/money/investing/article-2471487/Five-funds-invest-solar-wind-renewable-energy.html?ito=feeds-newsxml
Did you take a close look at the Rns and the links I've posted? In my opinion, It was an excellent Rns! They're a great read! Also, there are so few shares on offer and she could easily move... As Always... DYOR!
Are so few shares on offer... Could this be the dark horse of the day?:)